Doctolib vs Flo

Nvidia invests in Doctolib, Pigment, Genesis AI, Entalpic

European tech startups raised €15.8 billion in September, nearly five times August's €3.2 billion, with the UK attracting the largest share (46%). Mega-deals included Mistral's €3 billion Series D and Nscale's $3.36 billion convertible notes; even excluding these, funding tripled month-over-month. Nvidia continued its European expansion by announcing minority investments in four French startups (Doctolib, Genesis AI, Pigment, Entalpic) and five UK startups (Boltz, Foresight, Hiverge, Prima Mente, Riverlane), as part of nearly €9 billion in European commitments. CEO Jensen Huang also announced a $250 million compute donation to UK AI safety and research. Critics question circular financing, while Huang advocates continued dialogue with Chinese AI firms. These moves follow Nvidia's recent agreement to acquire Hugging Face for about $12.9 billion.

• European startups raised €15.8 billion in September, nearly five times August's €3.2 billion.
• Nvidia announced minority investments in four French (Doctolib, Genesis AI, Pigment, Entalpic) and five UK (Boltz, Foresight, Hiverge, Prima Mente, Riverlane) startups, with total European commitment near €9 billion.
• Mistral raised €3 billion in Series D at a valuation over €21 billion, the largest equity round for a European tech company.

Nvidia Invests in Four French Tech Companies

Nvidia has announced investments in four French technology companies during Jensen Huang's visit to Paris. The companies are Doctolib, a healthcare appointment platform; Genesis AI, a robotics startup; Pigment, a financial planning software maker; and Entalpic, a materials research startup. The deals are minority stakes, but the specific amounts and equity sizes were not disclosed. Nvidia's investment in Doctolib is intended to support its development of AI agents and a digital health companion. This move is part of Nvidia's broader commitment of nearly $10 billion to Europe's tech ecosystem, with plans to announce an additional $2 billion in European deals within a week. The investments have drawn criticism over potential circular financing, where AI firms use the funds to buy Nvidia chips, but Huang rejects these claims.

• Nvidia invests in Doctolib, Genesis AI, Pigment, and Entalpic.
• The investments are minority stakes; amounts undisclosed.
• Investment in Doctolib supports its AI agent and health companion work.

Vienna Startup Ovulyx Launches Couples-Focused Cycle Tracking App

Stefan Renzler, a Vienna-based developer, has launched Ovulyx, a cycle tracking app designed for couples, allowing both partners to view cycle phases and share an experience log to discover what helps during each phase. Users can track mood, energy, symptoms, and bleeding, with predictions for period, PMS, and fertile window. Partners connect via an invitation code and see a dedicated view with supportive actions. The app also supports trying for a baby and menopause, and allows import from Flo and MyNFP. Available on iOS, Android, and web in 29 languages across 152 countries, it offers a 30-day free trial, with Premium at €4.99 monthly or €49.99 yearly. Prioritizing privacy, data is stored in Western Europe under GDPR, and the app does not sell data or use health data for advertising. Ovulyx competes with Flo for Partners and Clue Connect.

• Ovulyx is a cycle tracking app for couples, launched by Vienna-based developer Stefan Renzler.
• The app is available on iOS, Android, and web in 29 languages across 152 countries.
• Premium costs €4.99 per month or €49.99 per year after a 30-day free trial, including one partner connection.

CIPA Private Right of Action Kept, Shifting Privacy to Research

California's legislature passed a compromise version of SB-690, maintaining most of the private right of action provisions of the California Invasion of Privacy Act (CIPA). This means that juries, rather than regulators, will set privacy standards in the state, as individuals can sue companies for online tracking practices. With over 4,000 CIPA lawsuits filed, mostly against legitimate businesses, the shift emphasizes the need for companies to align data practices with consumer (and juror) expectations. The author argues that privacy compliance should now be research-driven, focusing on customer attitudes, rather than purely legal compliance. This could lead to a competitive advantage for customer-centric businesses over Big Tech, which may face greater legal exposure.

• California passed a compromise version of SB-690, preserving most of the private right of action under CIPA.
• More than 4,000 CIPA lawsuits have been filed, mostly against legitimate businesses.
• A jury verdict against Meta involved data collection from the Flo menstrual tracking app.

Flo Health Appoints Rina Hahn as Chief Marketing Officer

Flo Health has appointed Rina Hahn as Chief Marketing Officer, announced August 26, 2026.